About FABTECH

Founded: 2001
Employees: 187
CEO: Ashwani Singh
WebsiteView website: www.fabtechnologies.com

Fabtech Technologies Limited operates as a biopharma engineering company that provides aseptic manufacturing facilities internationally. The company offers designing, engineering, procurement, installation, and testing of pharmaceutical equipment. It serves pharmaceuticals, biotech, and healthcare companies. The company was founded in 2001 and is based in Mumbai, India.

Recent FABTECH News & Updates

New Risk • May 05

New minor risk - Dividend sustainability

The company has a short dividend paying track record. Less than a year of continuous dividend payments. Dividend yield: 0.4% This is considered a minor risk. For dividend focussed investors, companies that have not established a long-term track record of consistently maintaining or growing dividends are less attractive than those companies that have a long track record. Those that have a long track record have proven their underlying business is stable enough to consistently maintain or grow the dividend and that the company considers maintaining the dividend to be one of its priorities. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (21% accrual ratio). Minor Risks Short dividend paying track record (less than a year of continuous dividend payments). Share price has been volatile over the past 3 months (9.1% average weekly change). Profit margins are more than 30% lower than last year (8.9% net profit margin). Market cap is less than US$100m (₹7.37b market cap, or US$77.3m).

Recent updates

No updates

Fabtech Technologies Limited Stock Price

FABTECH Share Price Performance

FABTECH Community Narratives

Trending Discussion

Recently Updated Narratives

Snowflake Analysis

Fabtech Technologies Limited Key Details

About FABTECH

Recent FABTECH News & Updates

New minor risk - Dividend sustainability

Fabtech Technologies' (NSE:FABTECH) Sluggish Earnings Might Be Just The Beginning Of Its Problems

High number of new and inexperienced directors

Recent updates

Fabtech Technologies Limited Competitors

Sun Pharmaceutical Industries

Divi's Laboratories

Torrent Pharmaceuticals

Cipla